MELA
Sciences Inc (NASDAQ:MELA) soared 9.18% to $3.45. The Company announced
positive results of its study of MelaFind with German dermatologists. The study
demonstrated that dermatologists who incorporated MelaFind into their biopsy
decision-making process for the detection of melanoma at its earliest, most
curable stages outperformed those who did not have the MelaFind information.
The study was conducted in collaboration with the German Cooperative Oncology
Group and German Skin Cancer Society. I
Merge
Healthcare Inc (NASDAQ:MRGE) jumped up 8.42% to $3.22 on a traded volume of
378k shares. The Company was named the number one global market leader in
providing vendor neutral archive solutions by InMedica. InMedica is a division of IMS Research.
Staples
Inc (NASDAQ:SPLS) decreased 1.62% to $13.01.The Company announced that Nexus 7
from Google is available for pre-sale. Nexus 7 8GB and 16GB will be available
in Staples stores nationwide and at Staples.com later this month.
Acme
Packet Inc (NASDAQ:APKT) declined 4.26% to $15.07 after the Company estimated
second quarter results below expectations on continued weakness in the North
American telecom service provider market. The
Company expects second-quarter profit of 12 cents to 13 cents per share. The
Company estimates revenue between $66 million and $68 million. The gross margin
is expected to range between 79% and 80%. However, analysts were expecting
earnings of 18 cents per share on revenue of $73.9 million.
Plains
Exploration & Production Company (NYSE:PXP) increased 3.61% to $38.19 after
the Company announced preliminary second quarter results. The Company expects
daily sales volumes of approximately 98 thousand barrels of oil equivalent per
day. PXP expects approximate $220 million pre-tax gain on mark-to-market
derivative contracts Brent crude oil price averaged $108.73 per barrel. The
Company expects Brent crude oil price to be around $108.73 per barrel for the
second-quarter 2012.
The
Company is scheduled to release 2012 second quarter results on August 2, 2012.
No comments:
Post a Comment